Anti-Glycation and Well-Ageing Effects of Inula britannica Flower Extract: From AGEs-RAGE Signalling to a Vehicle-Controlled Split-Face Study
Year: 2026
Type: article
Abstract: Objective: This study was conducted to characterize an Inula britannica L. flower extract (IB) and evaluate its anti-glycation and anti-ageing effects on Methylglyoxal (MGO)-challenged human dermal fibroblasts via a vehicle-controlled split-face study. Methods: The extract was prepared after characterization via high-performance liquid chromatography (HPLC) and ultraviolet (UV) detection. MGO-challenged UVAP7 fibroblasts were assessed for Nε-(carboxymethyl) lysine (CML), the receptor for advanced glycation end-products (RAGE), nuclear factor kappa-B (NF-κB), interleukin (IL)-6, IL-8, and senescence-associated markers of β-galactosidase, p16, and Lamin B1 via flow cytometry, Western blotting, enzyme-linked immunosorbent assay, and quantitative real-time PCR. Cross-sectional datasets of facial skin autofluorescence (n = 114) and Commission Internationale de l’Éclairage (CIE) b* (n = 162) were used to model their associations with chronological age. A 56-day, participant-blinded split-face study involving 36 adults was performed to evaluate the anti-glycation and well-ageing effect of a topical formulation containing 0.5% IB or its vehicle. Results: The total phenol content in IB reached 3.0–4.0% using the UV method, consisting of many caffeoyls from the HPLC analysis. At 0.016%, IB significantly inhibited MGO-induced positive cells of CML and RAGE by 82.97% and 96.69%, respectively; the total abundance of NF-κB protein was reduced by 90.32%; and cytokine secretion and senescence-associated markers improved. Age was positively associated with skin autofluorescence of AGEs (R2 = 0.8003) and CIE b* values (R2 = 0.5464). In the split-face study, at day 56, when compared to the vehicle-treated side, the IB-treated side showed significantly lower skin autofluorescence of AGEs, CIE b* values, under-eye wrinkle scores, and crow’s feet scores, but a higher high-intensity dermal echo parameter. Using the age-equivalent estimates derived from a population regression model, the effects of post-IB treatment on skin AGEs and yellowness showed a reduction when compared to pre-IB treatment. Conclusions: IB attenuates MGO-induced glycation and senescence-related responses in dermal fibroblasts through the AGE-RAGE pathway to improve skin yellowness, echogenicity, and periocular wrinkles. These findings support further investigation of chemically standardized IB and its potential application in skin ageing.
Source: Cosmetics
Language: English
Topic: Skin Protection and Aging
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,172
OpenAlex ID: W7236659702
